This suggests the importance of interventions for patients who have multiple handovers during their admission, especially with the increasing use of night-float and nonteaching hospitalist services in academic centers. In addition, interventions can be designed and implemented specifically for those patients who are particularly vulnerable, such as elderly patients or those without a high degree of education.
At least 1 study has suggested that placing physician photographs in the patients' rooms may help them to identify physicians. 9 At the same time, patients should be encouraged to take specific measures to stay informed about who is involved in their care and what the responsibility level of each caregiver is. Going 1 step further, the Lewis Blackman Hospital Patient Safety Act, 10 recently enacted in South Carolina, mandates that all hospital personnel wear appropriate name tags that identify their name and their role to patients and that patients are provided with education on how to immediately contact the attending physician in charge of their care.
There are several limitations of this study. This single institution study may not be generalizable to other settings, such as community hospitals. Loss to follow-up raises concerns of selection bias. Fortunately, patients who were lost to follow-up did not significantly differ by their ability to correctly identify their inpatient physician. Patients lost to follow-up were, however, more likely to be African American, male, hospitalized longer, hospitalized in the last year, and without a primary care physician at the University of Chicago, highlighting the difficulty in following up this group of patients. Third, patients may not have understood the questions or misinterpreted the question to refer to their primary care physician. Because of this, during pilot testing of earlier questions, we added the phrase "caring for you in the hospital."
Despite these limitations, the majority of hospitalized patients are unable to name someone in charge of their care. This suggests that academic hospitals should focus on improving the ability of patients to understand the names and roles of their inpatient physicians. 
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A Novel Therapy for Lymphedema
T
here is a broad differential to consider when evaluating a patient with angioedema, which can include capillary leak syndrome and lymphedema. Systemic capillary leak syndrome typically presents with hypotension, hemoconcentration, hypoalbuminemia, monoclonal gammopathy, and marked plasma leakage resulting in diffuse edema.
1 Prophylactic treatment with terbutaline sulfate and theophylline has been found to be effective for the prevention of systemic capillary leak syndrome exacerbations. 2 The other unusual consideration is lymphedema, which is notoriously resistant to therapy, and only supportive measures are available (physical therapy, external compression, and surgery). We describe herein a patient with lymphedema who benefited from treatment with theophylline and terbutaline.
Report of a Case.
A 53-year-old woman was referred for evaluation of recurrent angioedema that did not respond to several therapeutic modalities, including diuretics. Unusual features in her history included involvement of her abdominal wall and all 4 extremities with no pulmonary edema. Physical examination revealed nonpitting edema of her lower and upper extremities, as well as an indurated abdominal wall. Systemic capillary leak syndrome was 1 Evaluation included a normal C1 esterase inhibitor level; serum immunofixation electrophoresis showed a monoclonal IgG band (commonly seen in systemic capillary leak syndrome), which was eventually diagnosed as monoclonal gammopathy of unknown significance. Given the abnormal appearance of her abdominal wall, amyloidosis was considered. Results from a fine-needle aspiration were negative for amyloid. Findings from an abdominal wall punch biopsy were consistent with lymphedema, with scattered dilated capillary lymphatic spaces in the superficial and deep dermis. Evaluation for a cause of lymphedema included an evaluation for malignant neoplasms with a full-body computed tomographic scan showing axillary lymphadenopathy. An axillary lymph node biopsy specimen was negative for malignant cells. One week after the initiation of terbutaline and theophylline therapies, there was a marked improvement of her lymphedema. Her weight decreased by 14 kg after 10 months of treatment ( Figure,  A and B) . There was a direct correlation identified between the dose of terbutaline and the degree of lymphedema. Attempts to wean the terbutaline from 5 tablets to less than 3 tablets daily resulted in increased edema and weight, which would resolve by resuming the higher dose (Figure, C) .
Comment. Lymphedema is caused by insufficient lymph transport owing to lymphatic hypoplasia, impaired lymphatic function, or obstruction of lymph flow. 3 Increased lymphatic endothelial cell permeability is probably an important contributor. An increased cyclic adenosine monophosphate (cAMP) level is known to decrease endothelial cell permeability. 4 Terbutaline increases cAMP level by stimulating adenyl cyclase. 5 Theophylline increases intracellular cAMP by inhibiting phosphodiesterase. 6 With both medications contributing to an increase in cAMP level, this likely resulted in decreased endothelial cell permeability. We propose the use of this therapeutic modality for patients with idiopathic lymphedema. 
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